New drug substantially extends survival in pancreatic cancer
Tuesday, September 16, 2008 - 09:43
in Health & Medicine
A new form of chemotherapy that destroys new blood vessels that grow around tumors has produced excellent results in a phase II trial of patients with inoperable pancreatic cancer, researchers report at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.